These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 24410614)

  • 1. Does high-dose coenzyme Q10 improve oxidative damage and clinical outcomes in Parkinson's disease?
    Seet RC; Lim EC; Tan JJ; Quek AM; Chow AW; Chong WL; Ng MP; Ong CN; Halliwell B
    Antioxid Redox Signal; 2014 Jul; 21(2):211-7. PubMed ID: 24410614
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Randomized, double-blind, placebo-controlled pilot trial of reduced coenzyme Q10 for Parkinson's disease.
    Yoritaka A; Kawajiri S; Yamamoto Y; Nakahara T; Ando M; Hashimoto K; Nagase M; Saito Y; Hattori N
    Parkinsonism Relat Disord; 2015 Aug; 21(8):911-6. PubMed ID: 26054881
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Coenzyme Q10 dose-escalation study in hemodialysis patients: safety, tolerability, and effect on oxidative stress.
    Yeung CK; Billings FT; Claessens AJ; Roshanravan B; Linke L; Sundell MB; Ahmad S; Shao B; Shen DD; Ikizler TA; Himmelfarb J
    BMC Nephrol; 2015 Nov; 16():183. PubMed ID: 26531095
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A randomized clinical trial of high-dosage coenzyme Q10 in early Parkinson disease: no evidence of benefit.
    ; Beal MF; Oakes D; Shoulson I; Henchcliffe C; Galpern WR; Haas R; Juncos JL; Nutt JG; Voss TS; Ravina B; Shults CM; Helles K; Snively V; Lew MF; Griebner B; Watts A; Gao S; Pourcher E; Bond L; Kompoliti K; Agarwal P; Sia C; Jog M; Cole L; Sultana M; Kurlan R; Richard I; Deeley C; Waters CH; Figueroa A; Arkun A; Brodsky M; Ondo WG; Hunter CB; Jimenez-Shahed J; Palao A; Miyasaki JM; So J; Tetrud J; Reys L; Smith K; Singer C; Blenke A; Russell DS; Cotto C; Friedman JH; Lannon M; Zhang L; Drasby E; Kumar R; Subramanian T; Ford DS; Grimes DA; Cote D; Conway J; Siderowf AD; Evatt ML; Sommerfeld B; Lieberman AN; Okun MS; Rodriguez RL; Merritt S; Swartz CL; Martin WR; King P; Stover N; Guthrie S; Watts RL; Ahmed A; Fernandez HH; Winters A; Mari Z; Dawson TM; Dunlop B; Feigin AS; Shannon B; Nirenberg MJ; Ogg M; Ellias SA; Thomas CA; Frei K; Bodis-Wollner I; Glazman S; Mayer T; Hauser RA; Pahwa R; Langhammer A; Ranawaya R; Derwent L; Sethi KD; Farrow B; Prakash R; Litvan I; Robinson A; Sahay A; Gartner M; Hinson VK; Markind S; Pelikan M; Perlmutter JS; Hartlein J; Molho E; Evans S; Adler CH; Duffy A; Lind M; Elmer L; Davis K; Spears J; Wilson S; Leehey MA; Hermanowicz N; Niswonger S; Shill HA; Obradov S; Rajput A; Cowper M; Lessig S; Song D; Fontaine D; Zadikoff C; Williams K; Blindauer KA; Bergholte J; Propsom CS; Stacy MA; Field J; Mihaila D; Chilton M; Uc EY; Sieren J; Simon DK; Kraics L; Silver A; Boyd JT; Hamill RW; Ingvoldstad C; Young J; Thomas K; Kostyk SK; Wojcieszek J; Pfeiffer RF; Panisset M; Beland M; Reich SG; Cines M; Zappala N; Rivest J; Zweig R; Lumina LP; Hilliard CL; Grill S; Kellermann M; Tuite P; Rolandelli S; Kang UJ; Young J; Rao J; Cook MM; Severt L; Boyar K
    JAMA Neurol; 2014 May; 71(5):543-52. PubMed ID: 24664227
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Coenzyme Q10 for Patients with Parkinson's Disease: A Systematic Review and Meta-Analysis.
    Negida A; Menshawy A; El Ashal G; Elfouly Y; Hani Y; Hegazy Y; El Ghonimy S; Fouda S; Rashad Y
    CNS Neurol Disord Drug Targets; 2016; 15(1):45-53. PubMed ID: 26553164
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ubiquinol is superior to ubiquinone to enhance Coenzyme Q10 status in older men.
    Zhang Y; Liu J; Chen XQ; Oliver Chen CY
    Food Funct; 2018 Nov; 9(11):5653-5659. PubMed ID: 30302465
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison study of plasma coenzyme Q10 levels in healthy subjects supplemented with ubiquinol versus ubiquinone.
    Langsjoen PH; Langsjoen AM
    Clin Pharmacol Drug Dev; 2014 Jan; 3(1):13-7. PubMed ID: 27128225
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Randomized, double-blind, placebo-controlled trial on symptomatic effects of coenzyme Q(10) in Parkinson disease.
    Storch A; Jost WH; Vieregge P; Spiegel J; Greulich W; Durner J; Müller T; Kupsch A; Henningsen H; Oertel WH; Fuchs G; Kuhn W; Niklowitz P; Koch R; Herting B; Reichmann H;
    Arch Neurol; 2007 Jul; 64(7):938-44. PubMed ID: 17502459
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pilot trial of high dosages of coenzyme Q10 in patients with Parkinson's disease.
    Shults CW; Flint Beal M; Song D; Fontaine D
    Exp Neurol; 2004 Aug; 188(2):491-4. PubMed ID: 15246848
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The efficacy and safety of coenzyme Q10 in Parkinson's disease: a meta-analysis of randomized controlled trials.
    Zhu ZG; Sun MX; Zhang WL; Wang WW; Jin YM; Xie CL
    Neurol Sci; 2017 Feb; 38(2):215-224. PubMed ID: 27830343
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of Coenzyme Q
    Rivara MB; Yeung CK; Robinson-Cohen C; Phillips BR; Ruzinski J; Rock D; Linke L; Shen DD; Ikizler TA; Himmelfarb J
    Am J Kidney Dis; 2017 Mar; 69(3):389-399. PubMed ID: 27927588
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Coenzyme Q10 in Parkinson's disease. Symptomatic or neuroprotective effects?].
    Storch A
    Nervenarzt; 2007 Dec; 78(12):1378-82. PubMed ID: 17508194
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Altered redox state of platelet coenzyme Q10 in Parkinson's disease.
    Götz ME; Gerstner A; Harth R; Dirr A; Janetzky B; Kuhn W; Riederer P; Gerlach M
    J Neural Transm (Vienna); 2000; 107(1):41-8. PubMed ID: 10809402
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasma coenzyme Q10 response to oral ingestion of coenzyme Q10 formulations.
    Bhagavan HN; Chopra RK
    Mitochondrion; 2007 Jun; 7 Suppl():S78-88. PubMed ID: 17482886
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dose ranging and efficacy study of high-dose coenzyme Q10 formulations in Huntington's disease mice.
    Smith KM; Matson S; Matson WR; Cormier K; Del Signore SJ; Hagerty SW; Stack EC; Ryu H; Ferrante RJ
    Biochim Biophys Acta; 2006 Jun; 1762(6):616-26. PubMed ID: 16647250
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of Coenzyme Q10 supplementation on antioxidant enzymes activity and oxidative stress of seminal plasma: a double-blind randomised clinical trial.
    Nadjarzadeh A; Shidfar F; Amirjannati N; Vafa MR; Motevalian SA; Gohari MR; Nazeri Kakhki SA; Akhondi MM; Sadeghi MR
    Andrologia; 2014 Mar; 46(2):177-83. PubMed ID: 23289958
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Coenzyme Q10 administration suppresses both oxidative and antioxidative markers in hemodialysis patients.
    Sakata T; Furuya R; Shimazu T; Odamaki M; Ohkawa S; Kumagai H
    Blood Purif; 2008; 26(4):371-8. PubMed ID: 18509244
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuroprotective effects of coenzyme Q10 on paraquat-induced Parkinson's disease in experimental animals.
    Attia HN; Maklad YA
    Behav Pharmacol; 2018 Feb; 29(1):79-86. PubMed ID: 28902670
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of coenzyme Q10 in early Parkinson disease: evidence of slowing of the functional decline.
    Shults CW; Oakes D; Kieburtz K; Beal MF; Haas R; Plumb S; Juncos JL; Nutt J; Shoulson I; Carter J; Kompoliti K; Perlmutter JS; Reich S; Stern M; Watts RL; Kurlan R; Molho E; Harrison M; Lew M;
    Arch Neurol; 2002 Oct; 59(10):1541-50. PubMed ID: 12374491
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ubiquinol (reduced Coenzyme Q10) in patients with severe sepsis or septic shock: a randomized, double-blind, placebo-controlled, pilot trial.
    Donnino MW; Mortensen SJ; Andersen LW; Chase M; Berg KM; Balkema J; Radhakrishnan J; Gazmuri RJ; Liu X; Cocchi MN
    Crit Care; 2015 Jul; 19(1):275. PubMed ID: 26130237
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.